IRIS
CAVALLARO, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.186
NA - Nord America 2.495
EU - Europa 2.486
SA - Sud America 1.056
AF - Africa 82
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.333
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.362
SG - Singapore 1.775
CN - Cina 1.191
BR - Brasile 885
SE - Svezia 656
HK - Hong Kong 602
IT - Italia 598
RO - Romania 268
VN - Vietnam 246
DE - Germania 203
RU - Federazione Russa 201
GB - Regno Unito 129
IN - India 94
FI - Finlandia 83
CA - Canada 75
AR - Argentina 73
FR - Francia 55
IE - Irlanda 48
NL - Olanda 47
ES - Italia 45
PL - Polonia 45
MX - Messico 40
TR - Turchia 40
ID - Indonesia 37
BD - Bangladesh 36
AT - Austria 30
CO - Colombia 27
IR - Iran 26
ZA - Sudafrica 25
EC - Ecuador 22
JP - Giappone 22
KR - Corea 21
AU - Australia 17
IQ - Iraq 14
PE - Perù 14
EG - Egitto 13
MA - Marocco 13
UA - Ucraina 12
CL - Cile 11
PK - Pakistan 11
PY - Paraguay 11
TN - Tunisia 10
VE - Venezuela 10
BE - Belgio 9
MY - Malesia 9
AE - Emirati Arabi Uniti 8
PT - Portogallo 8
UZ - Uzbekistan 8
DK - Danimarca 7
LT - Lituania 7
NZ - Nuova Zelanda 7
CH - Svizzera 6
IL - Israele 6
DZ - Algeria 5
NP - Nepal 5
RS - Serbia 5
BG - Bulgaria 4
JM - Giamaica 4
JO - Giordania 4
PH - Filippine 4
SA - Arabia Saudita 4
SC - Seychelles 4
TW - Taiwan 4
DO - Repubblica Dominicana 3
GR - Grecia 3
HR - Croazia 3
KE - Kenya 3
KZ - Kazakistan 3
LB - Libano 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GT - Guatemala 2
HU - Ungheria 2
LV - Lettonia 2
LY - Libia 2
NO - Norvegia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
LU - Lussemburgo 1
MK - Macedonia 1
Totale 10.325
Salva come PNG Salva come JPEG
Città #
Singapore 727
Hong Kong 591
Dallas 457
Shanghai 320
Ashburn 264
Hefei 239
Princeton 213
Lawrence 212
Beijing 186
Milan 129
New York 107
São Paulo 95
Ho Chi Minh City 92
Munich 78
Moscow 75
Los Angeles 67
Boardman 60
Helsinki 56
Hanoi 54
Rome 49
Dublin 47
Warsaw 34
Montreal 31
The Dalles 29
Rio de Janeiro 25
Atlanta 24
Brooklyn 23
Frankfurt am Main 23
Poplar 23
Stockholm 23
Turku 23
Chennai 22
Pune 22
Tokyo 22
Belo Horizonte 20
Phoenix 20
Brasília 19
Denver 19
London 19
Seattle 19
Guangzhou 18
Nuremberg 18
Orem 18
Pittsburgh 18
Johannesburg 17
San Francisco 17
Council Bluffs 16
Santa Clara 16
Ankara 15
Toronto 15
Vienna 15
Curitiba 14
Naples 14
Amsterdam 13
Boston 13
Houston 13
Turin 13
Chicago 12
Genoa 12
Guarulhos 11
Salvador 11
Tianjin 11
Washington 11
Fortaleza 10
Mexico City 10
Bogotá 9
Da Nang 9
Istanbul 9
Lima 9
Manchester 9
Quito 9
Apodaca 8
Biên Hòa 8
Brescia 8
Cairo 8
Jakarta 8
Secaucus 8
Buenos Aires 7
Bắc Ninh 7
Campinas 7
Changsha 7
Columbus 7
Dhaka 7
Haiphong 7
Lentate sul Seveso 7
Volta Redonda 7
Auckland 6
Carney 6
City of London 6
Dalton 6
Freiburg im Breisgau 6
Goiânia 6
Joinville 6
Kuala Lumpur 6
Manaus 6
Mumbai 6
Noci 6
Porto Alegre 6
Ribeirão Preto 6
San Jose 6
Totale 5.158
Salva come PNG Salva come JPEG
Nome #
Clozapine to N-Desmethylclozapine ratio in treatment resistant schizophrenia: clinical implications from psychopathology to cognition 333
Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes 192
Emotional reactivity in chronic schizophrenia: structural and functional brain correlates and the influence of adverse childhood experiences 182
Functional and structural brain correlates of theory of mind and empathy deficits in schizophrenia 108
Valutazione del funzionamento cognitivo ‘trasferibili’ alla pratica clinica: la brief assessment of cognition scale (BACS) e la schizophrenia cognition rating scale (SCORS) 102
'Theory' of mind impairment in patients affected by schizophrenia and in their parents 99
M51. EFFICACY OF “PRAGMACOM TRAINING” IN SCHIZOPHRENIA: A RCT ON A NOVEL PRAGMATIC INTERVENTION 95
It is time to address language disorders in schizophrenia: a RCT on the efficacy of a novel training targeting the pragmatics of communication (PragmaCom) 89
The cognitive architecture of verbal humor in schizophrenia 88
Cognitive Remediation for Inpatients With Schizophrenia: Effects of a Brief and Intensive Training 84
Get up! Functional mobility and metabolic syndrome in chronic schizophrenia: Effects on cognition and quality of life 82
Modeling the interplay of age at onset and sex on cognition in Schizophrenia 79
Cognitive reserve profiles are associated with outcome in schizophrenia 75
Adult Consequences of Neurodevelopmental Disorders 74
ANTIPSYCHOTIC-INDUCED TARDIVE-DYSKINESIA - RECOGNITION, PREVENTION AND MANAGEMENT 73
Cogpack®: presupposti, descrizione e metodi a confronto",La riabilitazione cognitiva della schizofrenia 72
Targeting social cognition to improve functional outcome of patients with schizophrenia: Clinical evidences 72
The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy 72
Psychotic Disorders 71
A PILOT, OPEN STUDY ON THE TREATMENT OF REFRACTORY SCHIZOPHRENIA WITH RISPERIDONE AND CLOZAPINE 68
Targeting quality of life in schizophrenia: the fil rouge between metabolic syndrome and anxiety 67
Deconstructing heterogeneity in schizophrenia through language: a semi-automated linguistic analysis and data-driven clustering approach 67
Communicative-pragmatic abilities mediate the relationship between cognition and daily functioning in schizophrenia 66
Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex 66
The role of agency in schizophrenia: A pilot study on gaze agency 64
A leopard cannot change its spots: A novel pragmatic account of concretism in schizophrenia 64
Amygdala and the anterior cingulate in the emotional processing in bipolar disorder and schizophrenia. A 3.0 tesla BOLD fMRI study. XXVI Congress of the Collegium Internationale Neuro-Psychopharmacologicum (CINP), Munich 13-17 July. 63
Disentangling Cognitive Heterogeneity in Psychotic Spectrum Disorders 63
Cognitive remediation in schizophrenia: What happens after 10 years? 62
Adverse childhood experiences influence white matter microstructure in patients with schizophrenia 62
Cogpack®: prove di efficacia,La riabilitazione cognitiva della schizofrenia 62
Catechol-O-methyltransferase (COMT) genotype biases neural correlates of empathy and perceived personal distress in schizophrenia 62
Association study of COMT Val108/158Met polymorphism and treatment response to haloperidol, risperidone and clozapine 62
Obsessive-compulsive symptoms moderates the effects of cognitive functioning on quality of life in clozapine-treated schizophrenia 61
ADDing a piece to the puzzle of cognition in schizophrenia 61
Organic Mental Disorders and Psychiatric Issues in the Elderly 60
Adverse childhood experiences influence the detrimental effect of bipolar disorder and schizophrenia on cortico-limbic grey matter volumes 60
The brief assessment of cognition in schizophrenia. Normative data for the Italian population 60
Amygdala and the anterior cyngulate in the emotional processing in bipolar disorder and schizophrenia. A 3.0 tesla bold FMRI study 59
Antiprostatic effect of cimetidine in rats. 58
Psicopatologia e semeiotica della depressione: strumenti di valutazione 58
Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions 57
9-OH risperidone response in risperidone poor responders: An open study of drug response concordance 57
Amygdala and the anterior cingulate in the emotional processing in bipolar disorder and schizophrenia. A 3.0 tesla BOLD fMRI study. 57
Influence of catechol-O-methyltransferase Val(158) Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia 57
Psychopathology 57
Self-awareness of cognitive functioning in schizophrenia: Patients and their relatives 56
Longitudinal course of cognition in schizophrenia: Does treatment resistance play a role? 56
Improving outcome of treatment-resistant schizophrenia: effects of cognitive remediation therapy 56
Cognition in Schizophrenia: Modeling the Interplay between Interleukin-1β C-511T Polymorphism, Metabolic Syndrome, and Sex 55
Catechol-O-methyltransferase and saitohin gene polymorphism interaction: Effect on executive functions in schizophrenia 54
Association study of GSK-3 beta-50T/C polymorphism with haloperidol resistance in schizophrenia. 54
Achieving recovery in patients with schizophrenia through psycho-social interventions: A retrospective study 54
Belief Inflexibility and Cognitive Biases in Anorexia Nervosa—The Role of the Bias against Disconfirmatory Evidence and Its Clinical and Neuropsychological Correlates 53
Factors involved in the level of functioning of patients with schizophrenia according to latent variable modeling 53
Functional benefits of co-occurring autistic symptoms in schizophrenia is delimited by symptom severity 53
Non-Pharmacological Treatments 52
Is longer treatment better? A comparison study of 3 versus 6 months cognitive remediation in schizophrenia 52
Factors affecting cognitive remediation outcome in schizophrenia: The role of treatment resistance 51
Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise 51
Antipsicotici 51
Medium-term effectiveness of a new, prolonged-release, atypical antipsychotic: An objectives-based observational study [Effectiveness a medio termine di un nuovo antipsicotico atipico a rilascio prolungato: Uno studio osservazionale per obbiettivi] 51
Association study of a functional cathechol-O-methyltransferase polymorphism and cognitive rernediation in schizophrenia 51
A functional comparison of patients with schizophrenia between the North and South of Europe 50
Reality monitoring and paranoia in remitted delusional depression. 50
Analysis of three polymorphisms of the 5HT2a receptor gene in patients with tardive dyskinesia. 50
Can patients with schizophrenia have good mentalizing skills? Disentangling heterogeneity of theory of mind 50
Obesity influences white matter integrity in schizophrenia 50
Basi biologiche e trattamento della schizofrenia e del disturbo delirante 49
SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects. 48
Substance-Related Disorders 47
HTTLPR functional polymorphism in schizophrenia: Executive functions vs. sustained attention dissociation 47
A flexible-dose study of paliperidone ER in patients with non-acute schizophrenia previously unsuccessfully treated with oral risperidone 47
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disability 47
Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia 46
M202. SEX-RELATED DIFFERENCES IN CLOZAPINE SIDE EFFECTS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA 46
Antipsychotics, metabolic syndrome and schizophrenia: investigating the role of SREBF polymorphisms 44
Combined neurocognitive and metacognitive rehabilitation in schizophrenia: Effects on bias against disconfirmatory evidence 44
Computer-aided neurocognitive remediation in schizophrenia: Durability of rehabilitation outcomes in a follow-up study 43
Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-beta activity 43
Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations 42
Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study 42
Consensus five factor PANSS for evaluation of clinical remission: effects on functioning and cognitive performances 42
Exploring functioning in schizophrenia: Predictors of functional capacity and real-world behaviour 42
Dialectical Behavior Therapy Skills Training in Alcohol Dependence Treatment: Findings Based on an Open Trial. 42
On the Implementation of Computerized Adaptive Observations for Psychological Assessment 42
Factors affecting cognitive remediation response in schizophrenia: The role of COMT gene and antipsychotic treatment 41
Interleukin-1 beta, cognition and metabolic syndrome in schizophrenia 41
Abnormal cortico-limbic connectivity during emotional processing correlates with symptom severity in schizophrenia 41
White matter integrity, clinical symptoms and quality of life in schizophrenia: a DTI study 40
Disrupted effective connectivity of emotional circuitry in schizophrenia: a dynamic causal modeling study 40
Neuroleptic-induced extrapyramidal side effects. I: Tardive dyskinesia [GLI EFFETTI COLLATERALI EXTRAPIRAMIDALI INDOTTI DA NEUROLETTICI. I: LA DISCINESIA TARDIVA] 40
Exploring predictors of work competence in schizophrenia: The role of theory of mind 40
The role of premorbid adjustment in schizophrenia: Focus on cognitive remediation outcome 40
Unmet needs in the treatment of schizophrenia: The role of aripiprazole [Bisogni irrisolti nel trattamento della schizofrenia: Ruolo di aripiprazolo] 39
Brand-name versus generic clozapine for the treatment of resistant schizophrenia: Bioequivalence and interchangeability issues [Clozapina «brand» e clozapina generica nel trattamento della schizofrenia farmacoresistente: Bioequivalenza ed intercambiabilità] 39
COMT Val158Met and 5-HT1A-R-1019 C/G polymorphisms: effects on the negative symptom response to clozapine 39
Exploring the role of age as a moderator of cognitive remediation for people with schizophrenia 39
The effect of verbalization strategy on wisconsin card sorting test performance in schizophrenic patients receiving classical or atypical antipsychotics 38
Factors affecting the clinical response to haloperidol therapy in schizophrenia. 38
Totale 6.213
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.982
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.982
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 10 3 0 0 2 0 0
2021/2022149 0 0 0 41 20 9 9 12 16 9 15 18
2022/20231.359 493 256 87 15 47 172 50 95 70 26 21 27
2023/2024787 53 47 85 72 81 131 20 71 6 30 54 137
2024/20253.661 450 94 76 167 100 264 627 227 642 424 295 295
2025/20264.466 810 798 586 1.407 801 64 0 0 0 0 0 0
Totale 10.500